Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis

Clinical trial NCT01767701 · COMPLETED

Trial details

NCT number: NCT01767701
Sponsor: Queen Mary University of London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2013-04-01
Primary completion: 2014-09-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.